# Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis

> **NCT05451212** · PHASE1 · COMPLETED · sponsor: **Cabaletta Bio** · enrollment: 7 (actual)

## Conditions studied

- MuSK Myasthenia Gravis

## Interventions

- **BIOLOGICAL:** MuSK-CAART

## Key facts

- **NCT ID:** NCT05451212
- **Lead sponsor:** Cabaletta Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-23
- **Primary completion:** 2025-07-24
- **Final completion:** 2025-07-24
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2025-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05451212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05451212, "Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05451212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*